In this context, and following up our recent findings using breast cancer PDXs [2], the present study was designed with the double aim to elucidate i) the molecular mechanisms by which cell-intrinsic IFN signaling was triggered in cancer cells in response to chemotherapy, and ii) the ultimate contribution of the ISG fingerprint to the tumor response to treatment. The gene discussed is IFNA1; the disease is breast carcinoma.